MRSA guidelines: a matter of time

Expert Rev Anti Infect Ther. 2011 May;9(5):495-6. doi: 10.1586/eri.11.36.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Ceftaroline
  • Cephalosporins / therapeutic use
  • Community-Acquired Infections / complications
  • Community-Acquired Infections / drug therapy*
  • Community-Acquired Infections / microbiology
  • Guidelines as Topic
  • Humans
  • Methicillin Resistance*
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity*
  • Microbial Sensitivity Tests
  • Pneumonia / drug therapy*
  • Pneumonia / etiology
  • Pneumonia / microbiology
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology

Substances

  • Cephalosporins